The private equity real estate investment platform CityVest is now accepting investments for its latest offering, Catalyst Access Fund 2. The fund allows individual accredited investors to participate in the Catalyst Real Estate Fund with enhanced terms.
Catalyst is investing in multifamily properties targeting growth markets in Texas, Georgia, Florida and the Carolinas. This is a unique GP Co-Investment real estate private equity fund usually reserved only for institutional investors.
As a general partner (GP) co-investor, Catalyst is investing alongside the other GP equity enabling it to share in a percentage of the fees (the so-called "promote") that are charged to the limited partner (LP) investors in each individual acquisition.
Catalyst’s investment manager has significant experience having invested in close to $1 billion of properties and has historically generated a 35% realized net internal rate of return (IRR).
The Access Fund: Institutional real estate funds, such as the Catalyst Real Estate Fund, are typically unavailable to most individual investors because of the large minimum investment and limited access. Access funds pool multiple investor contributions into one bundle large enough to satisfy the minimum investment requirements, giving individuals access to these exclusive funds with as little as $25,000.
Since the access fund will aggregate a several million dollar investment, CityVest has negotiated a 12% preferred return that is compounded annually, as compared to the 8% preferred return for direct investors into Catalyst at the $100,000 minimum investment level.
Investment Terms: The access fund has limited availability, so access is limited to the first 100 investors with a hard closing date of April 22, 2022.
- Total Offering Amount: Up to $30 million
- Minimum Investment: $25,000
- Targeted Investor Net IRR: 20%-25%
- Preferred Return: 12%
- Historical Realized IRR: 35%
Explore private equity real estate offerings through platforms like CityVest and others on Benzinga’s alternative investments offering screener.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.